Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bd97b9fd81d7ab9674cce4370342e28 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
filingDate |
2012-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8a52206441ccf9e71507dd1e1a18c8a |
publicationDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180027641-A |
titleOfInvention |
Pharmaceutical composition comprising opioid agonist and sequestered antagonist |
abstract |
The present invention relates to a pharmaceutical composition comprising a plurality of multilayer beads having an oxycodone layer and an isolating subunit comprising a naltrexone and a blocking agent, in particular a pharmaceutical composition comprising a higher level of naltrexone, Compositions and methods of use. The compositions of the present invention also have a long-term T max for oxycodone release and a flat release profile of oxycodone over time. |
priorityDate |
2011-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |